$1.00
-0.04-3.85%
마지막 업데이트: Oct 30, 7:57 PM
Benzinga
Benzinga
Benzinga
토요일, 10월 31
Benzinga
© 2026 Benzinga | All Rights Reserved
ABVC BioPharma (ABVC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $-0.03 | $-0.06 | $-0.16 | $-0.05 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $795950 |
| Surprise | — | — | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 14, 2023 | $-0.68 | $-0.60 | -1333.3 % |
| Q1 | May 15, 2023 | $-0.60 | $-0.50 | -2000.0 % |
| Q4 | Mar 31, 2023 | $-1.50 | $-1.50 | 0.00 % |
| Q3 | Nov 15, 2021 | $-0.70 | $-0.40 | -7500.0 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 14, 2023 | $6.11K | $300.00K | -98.0 % |
| Q1 | May 15, 2023 | $128.27K | $128.00K | 0.21 % |
| Q4 | Mar 31, 2023 | $588.99K | $10.00K | 5789.9 % |
| Q3 | Nov 15, 2021 | $99.00K | $190.00K | -47.9 % |